Pharmaceutical compositions for nasal delivery
AssigneeTherakind Ltd.
InventorsJulie-Ann Penton, Susan Conroy, Louise Rawcliffe
Life of this patent
Estimating the term…
Abstract
There is described a dry powder pharmaceutical composition for intranasal delivery, wherein the composition comprises a therapeutically effective amount of a medicament for the treatment of a disorder of the alimentary system, in free form or in salt form; one or more mucoadhesives; and optionally one or more pharmaceutically acceptable excipients.
Claims36
A dry powder pharmaceutical composition for intranasal delivery, wherein the composition comprises a therapeutically effective amount of a medicament for the treatment of a disorder of the alimentary system, in free form or in salt form;
- one or more mucoadhesives;
- and optionally one or more pharmaceutically acceptable excipients.
(canceled)
(canceled)
-17. (canceled)
(canceled)
-44. (canceled)
A method of treating, preventing or alleviating a disorder of the alimentary system, said method comprising administering a therapeutically effective amount of a pharmaceutical composition in dry powder form, said composition comprising a medicament for the treatment of a disorder of the alimentary system, in free form or in salt form;
- one or more mucoadhesives;
- and optionally one or more pharmaceutically acceptable excipients.
(canceled)
(canceled)
-62. (canceled)
A dry powder nasal inhaler containing a medicament for treating, preventing or alleviating a disorder of the alimentary system, said medicament being in dry powder form, in free form or in salt form or a derivative thereof, one or more mucoadhesives;
- and optionally one or more pharmaceutically acceptable excipients.
-72. (canceled)
Dependencies are inferred from the claim text.